Cambridge, UK 07 February 2023– EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over Read More
Game-changing alternative asset investment marketplace closed its first equity funding round, enabling further product development and hiring plans ahead of its platform launch in Q1 2023. [February 7th 2023/London] – Darksquare, an alternative investment platform Read More
London UK, February 7th 2023: Syndi Health, a startup providing a digital infrastructure to offer personalised and effective digital health support within organisations, has raised £1.65 million (USD $2 million), in equity and grant funding. The investment comes Read More